Valion Bio, Inc. (VBIO)
NASDAQ: VBIO · Real-Time Price · USD
0.8800
-0.0509 (-5.47%)
At close: May 15, 2026, 4:00 PM EDT
0.9504
+0.0704 (8.00%)
After-hours: May 15, 2026, 7:59 PM EDT
Valion Bio Market Cap
Valion Bio has a market cap or net worth of $2.76 million as of May 15, 2026.
Market Cap
2.76M
Enterprise Value
-3.27M
1-Year Change
n/a
Ranking
Category
Stock Price
$0.88
Market Cap Chart
Since April 24, 2025, Valion Bio's market cap has decreased from $19.78M to $2.76M, a decrease of -86.03%. That is a compound annual growth rate of -84.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 11, 2026 | 119.98M | 15.63% |
| May 8, 2026 | 103.77M | -7.69% |
| May 7, 2026 | 112.42M | 0.97% |
| May 6, 2026 | 111.34M | 1.98% |
| May 5, 2026 | 109.18M | -2.88% |
| May 4, 2026 | 112.42M | 13.04% |
| May 1, 2026 | 99.45M | -6.12% |
| Apr 30, 2026 | 105.93M | 2.08% |
| Apr 29, 2026 | 103.77M | -4.95% |
| Apr 28, 2026 | 109.18M | -27.86% |
| Apr 27, 2026 | 151.33M | 665.18% |
| Apr 24, 2025 | 19.78M | - |
View and export this data all the way back to 2025. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| GeoVax Labs | 3.72M |
| Matinas BioPharma Holdings | 3.66M |
| GRI Bio | 3.12M |
| Azitra | 2.99M |
| Calidi Biotherapeutics | 2.90M |
| SciSparc | 2.82M |
| Virax Biolabs Group | 2.79M |
| Ensysce Biosciences | 2.57M |